Alvotech (ALVO) Operating Leases (2020 - 2025)
Alvotech (ALVO) posted Operating Leases of $150.1 million for Q4 2025, up 33.83% on a QoQ basis from $112.1 million in Q4 2024, and up 33.83% year-over-year from $112.1 million in Q4 2024.
Alvotech (ALVO) Operating Leases (2020 - 2025) Analysis & Trends
Alvotech's Operating Leases history runs 6 years deep, the most recent figure standing at $150.1 million for Q4 2025.
- Quarterly Operating Leases rose 33.83% year-over-year to $150.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $150.1 million (up 33.83% YoY) and the FY2025 annual result came in at $150.1 million, up 33.83% from the prior year.
- Operating Leases was $150.1 million for Q4 2025 at Alvotech, up from $112.1 million in the prior quarter.
- Across five years, Operating Leases topped out at $150.1 million in Q4 2025 and bottomed at $40.5 million in Q4 2022.
- A 5-year average of $108.0 million and a median of $115.3 million in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases plunged 66.82% — and 2023, when it surged 184.5%.
- Alvotech's Operating Leases stood at $122.1 million in 2021, then plunged by 66.82% to $40.5 million in 2022, then jumped by 184.5% to $115.3 million in 2023, then fell by 2.76% to $112.1 million in 2024, then surged by 33.83% to $150.1 million in 2025.
- Business Quant data shows ALVO's Operating Leases at $150.1 million in Q4 2025, $112.1 million in Q4 2024, and $115.3 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 150.08 Mn |
| Dec 31, 2024 | 112.14 Mn |
| Dec 31, 2023 | 115.32 Mn |
| Dec 31, 2022 | 40.53 Mn |
| Dec 31, 2021 | 122.14 Mn |
| Dec 31, 2020 | 108.95 Mn |